Form S-1/A IN8BIO, INC.
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/3/2026
- Equities close higher as softer jobs data quiets rate-hike expectations
- U.S. economy adds fewer jobs than expected as unemployment rate ticks higher
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Citi says rate volatility without Fed repricing is concerning
- U.S. credit-reporting stocks fall as FHFA weighs two-bureau mortgage rule
- Cantor Fitzgerald on Rivian (RIVN): 'pre-announced that it delivered 19,248 vehicles in 3Q26, above our estimate'
- DISH DBS emerges from bankruptcy, cuts debt by $4.35 billion
- Equities close higher as softer jobs data quiets rate-hike expectations
- Tanker struck by projectile in Strait of Hormuz
- AppLovin shares fall after court denies request against Unity
IN8bio, Inc (INAB) Files For up to $46M IPO
July 20, 2021 6:19 AM EDTIN8bio, Inc (NASDAQ: INAB) has fled for up to $46,000,000 IPO.
The company describes itself as: "We are a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of gamma-delta T cell therapies for the treatment of cancer. Gamma-delta T cells are... More
